By: J. Kerger MD
There were very few new interesting and no practice-changing data presented at the 2015 European Cancer Congress, compared to the ASCO Annual Meeting earlier this year. This lack of presentations is most probably due to the upcoming meeting of ESGO (European Society of Gynecologic Oncology), which was held in Nice end of October 2015.
(BELG J MED ONCOL 2015;9:225–28)
* (only possible for healthcare professionals with RIZIV/INAMI/MATRICULE working in the field of Oncology/Hemato-oncology in Belgium and Luxembourg with prescription authorisation)
** (for healthcare professionals with prescribing authorisation working outside the field of Oncology/Hemato-oncology in Belgium and Luxembourg as well as those without prescribing authorisation working as healthcare professional in Oncology/Hemato-oncology in Belgium and Luxembourg, plus persons without prescription authorisation working outside Belgium and Luxembourg, plus healthcare professionals with prescribing authorisation outside Belgium and Luxembourg plus non-healthcare professionals from outside or inside Belgium or Luxembourg)
Top
